Consequences of overhydration and the need for dry weight assessment

Contributions to Nephrology

Volumn 161, Issue , 2008, Pages 99-107

  Raimann, J ^a   Liu, L ^a   Ulloa, D ^a   Kotanko, P ^a   Levin, N ^a,b  

^a RENAL RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY WATER; HUMAN; METABOLIC DISORDER; METABOLISM; RENAL REPLACEMENT THERAPY; REVIEW;

BODY WATER; HUMANS; RENAL DIALYSIS; WATER-ELECTROLYTE IMBALANCE;

EID: 48049120684     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000130414     Document Type: Conference Paper

References (28)

1. Foley RN, Collins AJ: End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol 2007;18:2644-2648.
2. Yashiro M, Kamata T, Yamadori N, Tomita M, Muso E: Evaluation of markers to estimate volume status in hemodialysis patients: atrial natriuretic peptide, inferior vena cava diameter, blood volume changes and filtration coefficients of microvasculature. Ther Apher Dial 2007;11:131-137.
3. Oe B, de Fijter CW, Geers TB, Vos PF, Donker AJ, de Vries PM: Diameter of inferior caval vein and impedance analysis for assessment of hydration status in peritoneal dialysis. Artif Organs 2000;24:575-577.
4. Kouw PM, Kooman JP, Cheriex EC, Olthof CG, de Vries PM, Leunissen KM: Assessment of postdialysis dry weight: a comparison of techniques. J Am Soc Nephrol 1993;4:98-104.
5. Van de Pol AC, Frenken LA, Moret K, Baumgarten R, van der Sande FM, Beerenhout CM, et al: An evaluation of blood volume changes during ultrafiltration pulses and natriuretic peptides in the assessment of dry weight in hemodialysis patients. Hemodial Int 2007;11:51-61.
6. Zhu F, Leonard EF, Carter M, Levin NW: Continuous measurement of calf resistivity in hemodialysis patients using bioimpedance analysis. Conf Proc IEEE Eng Med Biol Soc 2006;1:5126-5128.
7. Ritz E, Passlick-Deetjen J, Zeier M, Amann K: Blood pressure on dialysis: an ongoing controversy. Saudi J Kidney Dis Transpl 2002;13:1-13.
8. Chien S, Li S, Shyy YJ: Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension 1998;31:162-169.
9. Koomans HA, Blankestijn PJ, Joles JA: Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 2004;15:524-537.
10. Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, et al: Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 2003;14:2775-2782.
11. Stella P, Manunta P, Mallamaci F, Melandri M, Spotti D, Tripepi G, et al: Endogenous ouabain and cardiomyopathy in dialysis patients. J Intern Med 2007.
12. Wang AY, Lai KN: The importance of residual renal function in dialysis patients. Kidney Int 2006;69:1726-1732.
13. Verhave JC, Hillege HL, Burgerhof JG, Janssen WM, Gansevoort RT, Navis GJ, et al: Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 2004;256:324-330.
14. Joffe HV, Adler GK: Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation. Heart Fail Rev 2005;10:31-37.
15. Avila-Diaz M, Ventura MD, Valle D, Vicente-Martinez M, Garcia-Gonzalez Z, Cisneros A, et al: Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis. Perit Dial Int 2006;26:574-580.
16. Ortega Marcos O, Rodriguez I, Gallar P, Oliet A, Vigil A: Importance of dry-weight assessment in well-being, appetite, nutritional status, and anaemia correction in haemodialysis patients. Nephrol Dial Transplant 1998;13:2424.
17. King D, Smith ML, Chapman TJ, Stockdale HR, Lye M: Fat malabsorption in elderly patients with cardiac cachexia. Age Ageing 1996;25:144-149.
18. King D, Smith ML, Lye M: Gastrointestinal protein loss in elderly patients with cardiac cachexia. Age Ageing 1996;25:221-223.
19. Mundinger TO, Cummings DE, Taborsky GJ Jr: Direct stimulation of ghrelin secretion by sympathetic nerves. Endocrinology 2006;147:2893-2901.
20. Bossola M, Tazza L, Giungi S, Luciani G: Anorexia in hemodialysis patients: an update. Kidney Int 2006;70:417-422.
21. Ozkahya M, Ok E, Cirit M, Aydin S, Akcicek F, Basci A, et al: Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant 1998;13:1489-1493.
22. Charra B, Bergstrom J, Scribner BH: Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis 1998;32:720-724.
23. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, et al: Long-term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention. BMJ 2007;334:885.
24. Ritz E, Dikow R, Morath C, Schwenger V: Salt - a potential 'uremic toxin'? Blood Purif 2006;24:63-66.
25. Keen ML, Gotch FA: The association of the sodium 'setpoint' to interdialytic weight gain and blood pressure in hemodialysis patients. Int J Artif Organs 2007;30:971-979.
26. Nette RW, Krepel HP, van den Meiracker AH, Weimar W, Zietse R: Specific effect of the infusion of glucose on blood volume during haemodialysis. Nephrol Dial Transplant 2002;17:1275-1280.
27. Maggiore Q, Pizzarelli F, Santoro A, Panzetta G, Bonforte G, Hannedouche T, et al: The effects of control of thermal balance on vascular stability in hemodialysis patients: results of the European randomized clinical trial. Am J Kidney Dis 2002;40:280-290.
28. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, et al: Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006;69:1222-1228.